Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 0.0 | 0.0 | 0.0 | 2.2 | 0.6 | 0.1 | 0.2 |
| Revenue growth | | | -100.0% | 274.7% | 316.2% | -41.6% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 1.7 | 2.0 | 1.3 | 1.6 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.5 | -1.4 | -1.2 | -1.3 |
| Gross margin | | | | 23.6% | -239.0% | -808.8% | -548.5% |
| Research and development | 0.8 | 0.1 | 0.2 | | | | |
| General and administrative | 1.2 | 1.4 | 1.9 | 1.7 | 2.0 | 1.3 | 1.6 |
| EBIT | -2.0 | -1.5 | -2.1 | -4.0 | -2.6 | -1.4 | -1.8 |
| EBIT margin | | | | -176.4% | -439.0% | -1008.8% | -748.5% |
| Pre-tax income | -3.0 | -2.1 | -6.0 | -6.9 | -4.7 | -3.1 | -3.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -3.0 | -2.1 | -6.0 | -6.9 | -4.7 | -3.1 | -3.0 |
| Net margin | | | | -310.1% | -779.2% | -2167.6% | -1202.6% |
| |
| Diluted EPS | ($0.17) | ($0.13) | ($0.44) | ($0.73) | ($2.65) | ($1.98) | ($2.07) |
| Shares outstanding (diluted) | 17.3 | 16.1 | 13.6 | 9.6 | 1.8 | 1.6 | 1.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|